Literature DB >> 1486458

Fronto-striatal cognitive deficits at different stages of Parkinson's disease.

A M Owen1, M James, P N Leigh, B A Summers, C D Marsden, N P Quinn, K W Lange, T W Robbins.   

Abstract

Groups of patients with idiopathic Parkinson's disease, either medicated or unmedicated, were compared with matched groups of normal controls on a computerized battery previously shown to be sensitive to frontal lobe dysfunction, including tests of planning, spatial working memory and attentional set-shifting. In a series of problems based on the 'Tower of London' test, medicated patients with Parkinson's disease were shown to be impaired in the amount of time spent thinking about (planning) the solution to each problem. Additionally, an impairment in terms of the accuracy of the solution produced on this test was only evident in those patients with more severe clinical symptoms and was accompanied by deficits in an associated test of spatial short-term memory. Medicated patients with both mild and severe clinical symptoms were also impaired on a related test of spatial working memory. In contrast, a group of patients who were unmedicated and 'early in the course' of the disease were unimpaired in all three of these tests. However, all three Parkinson's disease groups were impaired in the test of attentional set-shifting ability, although unimpaired in a test of pattern recognition which is insensitive to frontal lobe damage. These data are compared with those previously published from a group of young neurosurgical patients with localized excisions of the frontal lobes and are discussed in terms of the specific nature of the cognitive deficit at different stages of Parkinson's disease.

Entities:  

Mesh:

Year:  1992        PMID: 1486458     DOI: 10.1093/brain/115.6.1727

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  163 in total

1.  Cognition in non-demented Parkinson's disease vs essential tremor: A population-based study.

Authors:  Á Sánchez-Ferro; J Benito-León; E D Louis; I Contador; J Hernández-Gallego; V Puertas-Martín; F Bermejo-Pareja
Journal:  Acta Neurol Scand       Date:  2017-03-05       Impact factor: 3.209

Review 2.  Mild cognitive impairment in Parkinson's disease.

Authors:  J G Goldman; I Litvan
Journal:  Minerva Med       Date:  2011-12       Impact factor: 4.806

3.  The role of prefrontal dopamine D1 receptors in the neural mechanisms of associative learning.

Authors:  M Victoria Puig; Earl K Miller
Journal:  Neuron       Date:  2012-06-07       Impact factor: 17.173

4.  A symbolic/subsymbolic interface protocol for cognitive modeling.

Authors:  Patrick Simen; Thad Polk
Journal:  Log J IGPL       Date:  2010-10-01       Impact factor: 0.861

Review 5.  A review of cognitive impairment and differential diagnosis in idiopathic normal pressure hydrocephalus.

Authors:  Marta Picascia; Roberta Zangaglia; Sara Bernini; Brigida Minafra; Elena Sinforiani; Claudio Pacchetti
Journal:  Funct Neurol       Date:  2015 Oct-Dec

6.  L-dopa impairs learning, but spares generalization, in Parkinson's disease.

Authors:  Daphna Shohamy; Catherine E Myers; Kindiya D Geghman; Jacob Sage; Mark A Gluck
Journal:  Neuropsychologia       Date:  2005-09-16       Impact factor: 3.139

Review 7.  Preservation of function in Parkinson's disease: what's learning got to do with it?

Authors:  Jeff A Beeler
Journal:  Brain Res       Date:  2011-09-29       Impact factor: 3.252

8.  Meta-analysis of neuroimaging studies of the Wisconsin card-sorting task and component processes.

Authors:  Bradley R Buchsbaum; Stephanie Greer; Wei-Li Chang; Karen Faith Berman
Journal:  Hum Brain Mapp       Date:  2005-05       Impact factor: 5.038

9.  Function of striatum beyond inhibition and execution of motor responses.

Authors:  Matthijs Vink; René S Kahn; Mathijs Raemaekers; Martijn van den Heuvel; Maria Boersma; Nick F Ramsey
Journal:  Hum Brain Mapp       Date:  2005-07       Impact factor: 5.038

10.  Behavioral toxicology of cognition: extrapolation from experimental animal models to humans: behavioral toxicology symposium overview.

Authors:  Merle G Paule; Leonard Green; Joel Myerson; Maria Alvarado; Jocelyne Bachevalier; Jay S Schneider; Susan L Schantz
Journal:  Neurotoxicol Teratol       Date:  2012-01-28       Impact factor: 3.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.